BioPharm International-04-01-2016

April 01, 2016

The authors investigate the sufficiency of high-temperature short-time treatment in inactivate mouse minute virus contamination.

April 01, 2016

The authors review the technologies that may help bioprocessing become a truly continuous operation and present case studies that could contribute to the integration of upstream and downstream platforms.

April 01, 2016

Careful planning, adequate staffing levels, and experienced project managers can help avoid pitfalls of transferring processes from one facility to another.

April 01, 2016

The author describes common components of a relative potency bioassay and provides a framework for assay development, calculation, and control.

April 01, 2016

Collaboration and single-use technologies aided the rapid scale-up of Ebola vaccine manufacturing

April 01, 2016

Selecting a delivery method early on may be beneficial.

April 01, 2016

A modular cell-culture platform demonstrates accelerated process development.

April 01, 2016

Proven science-based strategies can help to accelerate vaccine development.

April 01, 2016

The authors provide application data to support the use of SEC beyond small-scale operations.

April 01, 2016

Global outbreaks energize vaccine R&D and drive production modernization.

April 01, 2016

Demand is driving expansion and consolidation of formulation and clinical trial materials services.

April 01, 2016

Industry experts provide insights on the challenges and importance of using buffers in downstream processing.

April 01, 2016

Click the title above to open the BioPharm International April 2016 issue in an interactive PDF format.